[Thrombotic microangiopathy (TMA) (1). TMA in the target organs of graft-versus-host disease]
- PMID: 10921348
[Thrombotic microangiopathy (TMA) (1). TMA in the target organs of graft-versus-host disease]
Similar articles
-
Thrombotic microangiopathy following bone marrow transplantation.Bone Marrow Transplant. 1994 Oct;14(4):495-504. Bone Marrow Transplant. 1994. PMID: 7858524 Review.
-
Thrombotic microangiopathy after allogeneic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes.Bone Marrow Transplant. 2004 Jun;33(11):1073-4. doi: 10.1038/sj.bmt.1704513. Bone Marrow Transplant. 2004. PMID: 15153944 No abstract available.
-
Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.Bone Marrow Transplant. 2004 Jun;33(11):1143-50. doi: 10.1038/sj.bmt.1704512. Bone Marrow Transplant. 2004. PMID: 15077133
-
Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis.Bone Marrow Transplant. 1998 Aug;22(4):351-7. doi: 10.1038/sj.bmt.1701359. Bone Marrow Transplant. 1998. PMID: 9722070
-
Thrombotic microangiopathy in transplantation and malignancy.Semin Thromb Hemost. 2005 Dec;31(6):691-9. doi: 10.1055/s-2005-925475. Semin Thromb Hemost. 2005. PMID: 16388420 Review.
Cited by
-
High titer of ADAMTS13 inhibitor associated with thrombotic microangiopathy of the gut and skeletal muscle after allogeneic hematopoietic stem cell transplantation.Int J Hematol. 2006 Jun;83(5):415-9. doi: 10.1532/IJH97.05157. Int J Hematol. 2006. PMID: 16787872